X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC PHARMA with IPCA Labs - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs IPCA LABS - Comparison Results

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA IPCA LABS ALEMBIC PHARMA/
IPCA LABS
 
P/E (TTM) x 26.5 27.9 95.0% View Chart
P/BV x 6.1 2.1 282.5% View Chart
Dividend Yield % 0.8 0.2 324.4%  

Financials

 ALEMBIC PHARMA   IPCA LABS
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-16
IPCA LABS
Mar-17
ALEMBIC PHARMA/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs792643 123.1%   
Low Rs443503 88.1%   
Sales per share (Unadj.) Rs167.0254.4 65.7%  
Earnings per share (Unadj.) Rs38.216.1 237.5%  
Cash flow per share (Unadj.) Rs42.029.8 141.0%  
Dividends per share (Unadj.) Rs4.001.00 400.0%  
Dividend yield (eoy) %0.60.2 371.2%  
Book value per share (Unadj.) Rs84.9194.6 43.6%  
Shares outstanding (eoy) m188.52126.20 149.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.72.3 164.1%   
Avg P/E ratio x16.235.7 45.4%  
P/CF ratio (eoy) x14.719.2 76.4%  
Price / Book Value ratio x7.32.9 246.9%  
Dividend payout %10.56.2 168.4%   
Avg Mkt Cap Rs m116,38372,300 161.0%   
No. of employees `000NA13.3 0.0%   
Total wages/salary Rs m4,2146,960 60.5%   
Avg. sales/employee Rs ThNM2,413.5-  
Avg. wages/employee Rs ThNM523.2-  
Avg. net profit/employee Rs ThNM152.4-  
INCOME DATA
Net Sales Rs m31,48732,106 98.1%  
Other income Rs m55226 24.4%   
Total revenues Rs m31,54232,332 97.6%   
Gross profit Rs m10,0604,448 226.2%  
Depreciation Rs m7221,730 41.8%   
Interest Rs m37241 15.3%   
Profit before tax Rs m9,3562,703 346.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,160675 319.9%   
Profit after tax Rs m7,1942,028 354.7%  
Gross profit margin %31.913.9 230.6%  
Effective tax rate %23.125.0 92.4%   
Net profit margin %22.86.3 361.7%  
BALANCE SHEET DATA
Current assets Rs m15,06617,340 86.9%   
Current liabilities Rs m7,6749,559 80.3%   
Net working cap to sales %23.524.2 96.9%  
Current ratio x2.01.8 108.2%  
Inventory Days Days67100 66.8%  
Debtors Days Days4157 71.5%  
Net fixed assets Rs m8,23720,779 39.6%   
Share capital Rs m377252 149.4%   
"Free" reserves Rs m15,41624,499 62.9%   
Net worth Rs m16,00524,553 65.2%   
Long term debt Rs m03,517 0.0%   
Total assets Rs m24,59439,595 62.1%  
Interest coverage x255.212.2 2,087.7%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x1.30.8 157.9%   
Return on assets %29.45.7 513.1%  
Return on equity %44.98.3 544.2%  
Return on capital %58.710.5 559.5%  
Exports to sales %55.748.6 114.6%   
Imports to sales %10.414.2 73.2%   
Exports (fob) Rs m17,55115,617 112.4%   
Imports (cif) Rs m3,2834,571 71.8%   
Fx inflow Rs m17,81115,617 114.0%   
Fx outflow Rs m5,3185,828 91.3%   
Net fx Rs m12,4939,790 127.6%   
CASH FLOW
From Operations Rs m9,3042,764 336.6%  
From Investments Rs m-3,105-1,432 216.9%  
From Financial Activity Rs m-1,959-1,591 123.1%  
Net Cashflow Rs m4,240-259 -1,638.3%  

Share Holding

Indian Promoters % 74.1 45.9 161.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.9 11.4 25.4%  
FIIs % 9.1 25.3 36.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 17.4 79.9%  
Shareholders   49,328 36,892 133.7%  
Pledged promoter(s) holding % 0.0 2.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   FDC LTD.  UNICHEM LAB  DR. REDDYS LAB  AJANTA PHARMA  ALEMBIC LTD  

Compare ALEMBIC PHARMA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Trade Marginally Higher; Pharma Sector Up 2.4%(11:30 am)

Stock markets in India are presently trading near the dotted line with positive bias. Sectoral indices are trading on a mixed note with stocks in the healthcare sector.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

Aug 21, 2017

Most Indians who cannot find jobs, look at becoming self-employed.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

Aug 22, 2017

Post demonetisation, a cut in bank savings deposits rates was in the offing.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Aug 24, 2017 12:43 PM

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA - TTK HEALTHCARE COMPARISON

COMPARE ALEMBIC PHARMA WITH

MARKET STATS